Pitolisant, a wake‐promoting agent devoid of psychostimulant properties: Preclinical comparison with amphetamine, modafinil, and solriamfetol

• Príomhchruthaitheoirí: Stéphane Krief (Údar), Isabelle Berrebi‐Bertrand (Údar), Isabelle Nagmar (Údar), Martin Giret (Údar), Simon Belliard (Údar), David Perrin (Údar), Marilyne Uguen (Údar), Philippe Robert (Údar), Jeanne‐Marie Lecomte (Údar), Jean‐Charles Schwartz (Údar), Olivier Finance (Údar), Xavier Ligneau (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Wiley, 2021-10-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Abstract Several therapeutic options are currently available to treat excessive daytime sleepiness (EDS) in patients suffering from narcolepsy or obstructive sleep apnea. However, there are no comparisons between the various wake‐promoting agents in terms of mechanism of action, efficacy, or safety....